Two G-protein-coupled receptors, angiotensin type 1 receptor (AT1R) and type 2 receptor (AT2R), mediate the majority of angiotensin II (Ang II) effects. It has long been believed that the AT2R is reduced to extremely low levels in adulthood but is abundantly expressed in the fetus. However, recent data from rats and mice do not support this notion. Employing Western blot analysis, we found a gradual increase in AT2R protein expression from fetal life to adulthood in brain, heart, lung, liver, and kidney. The reason for the discrepancy between our observations and the conventional concept is unknown. Evidence supporting a regression of the AT2R during maturation is derived largely from autoradiographic signals that were confined to the outline of fetal rats, implying that the previously reported high AT2R expression in the fetus might be valid only for skin. We therefore hypothesized that the ontogeny of angiotensin receptors in skin is opposite that in other organs. In the current experiment, we employed Western blot analysis to compare AT2R and AT1R protein expressions in skin with that in the brainstem of fetal and adult mice. Fetal brainstem expressed lower AT2R and higher AT1R protein compared to adult brainstem (AT2R/GAPDH: 0.08 ± 0.2 in fetus vs 7.6 ± 0.9 in adult, p < 0.05; AT1R/GAPDH: 5.9 ± 0.8 in fetus vs 0.7 ± 0.3 in adult, p < 0.05). In contrast, fetal skin expresses higher AT2R and lower AT1R protein compared to adult skin (AT2R/GAPDH: 0.95 ± 0.4 in fetus vs 0.04 ± 0.2 in adult, p < 0.05; AT1R/ GAPDH: 0.6 ± 0.2 in fetus vs 2.1 ± 0.5 in adult, p < 0.05). This expression profile was also confirmed by immunofluorescence. Using real-time RT-PCR, we could not detect any significant differences in mRNA of these two receptors in brainstem between fetal and adult mice. However, we found a higher AT2R mRNA and lower AT1R mRNA in the fetal skin compared to adult skin. The above results confirm our hypothesis that skin displays an expression profile of angiotensin receptors opposite that of other organs during development, suggesting that the currently held view concerning AT2R maturation is suitable only for skin. In other organs and tissues, adults express higher AT2R protein than does the fetus.
Introduction
Angiotensin II (Ang II) is a critical hormone that exerts multiple important functions in physiological as well as pathological conditions. 1 Two G-protein-coupled receptors, angiotensin type 1 receptors (AT1R) and type 2 receptors (AT2R), have been identified as the primary mediators of Ang II function. [2] [3] [4] [5] These two receptors co-express in the same cells, tissues, and organs, while evoking distinctly different effects. [6] [7] [8] [9] In the intact animal, Ang II simultaneously activates both AT1R and AT2R, and therefore its net effects depend on the integrated output from these two receptors. In most states, the AT1R is the predominant receptor subtype and masks the functions of the AT2R. Indeed, both central [10] [11] [12] and peripheral 13 administration of Ang II in fetal and adult animals evokes a pressor response, a typical effect of AT1R stimulation. On the other hand, the effects of AT2R activation emerge only after administration of Ang II plus an AT1R blocker, 14 or selective AT2R agonists such as CGP42112 15 and compound 21. 16 The AT2R has been generally believed be a vestigial receptor and play diminished role in adulthood. 1, 6, [17] [18] [19] [20] [21] This receptor is thought to be highly expressed and therefore the predominant receptor subtype in the fetus. After birth, however, AT2R expression is thought to rapidly decline. In the adult animal, most tissues express very low levels of the AT2R and some tissues have no AT2R expression at all. This notion primarily stems from the results of autoradiography, [22] [23] [24] [25] ligand binding, [26] [27] [28] [29] and in situ hybridization [30] [31] [32] [33] in studies published approximately two decades ago. Autoradiography and ligand binding evaluate the affinity of ligand for receptors, while in situ hybridization localizes the receptor mRNA. None of these techniques directly examine the receptor protein content.
Employing Western blotting analysis, we recently showed that AT2R protein expression was lower in the fetal brain and most other organs compared to adult animals. 34, 35 We further demonstrated that the AT2R was gradually upregulated from fetal life to adulthood. 34 To the best of our knowledge, this was the first study to directly evaluate the developmental changes of AT2R protein. More important, our data are distinctly opposite of the conventional notion that AT2R expression is down-regulated after birth. 1, 6, [17] [18] [19] [20] [21] A study by Grady et al. 25 is often cited as evidence for the dramatic decline of AT2R expression after birth. 1, 6, [17] [18] [19] [20] [21] Figure 1 in Grady et al.'s publication shows a strong AT2R radioactive signal in fetus and its dramatic disappearance within 24 hours after birth. 25 However, we surprisingly noticed that the majority of this AT2R radioactive signal was confined to the outline of the fetal images, 25 implying that the high AT2R expression in the fetus may be localized only to skin. We therefore hypothesize that the ontogeny of angiotensin receptors in skin is opposite that in other organs. This may be the cause for the discrepancy between our data and the currently prevailing notion on AT2R maturation. To address this hypothesis, we compared the developmental changes of AT2R protein expression between brainstem and skin in mice. In addition to AT2R, AT1R expression was also examined.
Methods

Animals
A total of 62 male c57BL/6 mice, including fetuses (~ three days before birth), neonates (~ three days after birth), juvenile (one to six weeks), and adults (10-14 weeks), were used in this experiment. The individual fetuses were taken from different pregnant female mice, and individual neonates were taken from different litters. The sex of the fetuses and neonates was identified by the sex-determining region Y (SRY) expression employing reverse-transcription-polymerase chain reaction (RT-PCR). All experiments were approved by the Institutional Animal Care and Use Committee of the University of Nebraska Medical Center and were carried out under the guidelines of the American Physiological Society and the United States National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Preparation of tissues
All mice were euthanized by CO 2, and the back hair was removed using commercially available hair removal cream (Nair). The brainstem and skin were removed and immediately frozen on dry ice, and stored at −80 °C. All tissues were taken from the same regions of each organ. The brainstem samples were taken from a rostral coronal section 0.5-2.0 mm of the obex. The skin samples were taken from the dorsal region.
Western blotting analysis
The tissues were homogenized in radioimmunoprecipitation (RIPA) buffer (50 mM Tris/HCl pH7.4, 150 mM NaCl, 2 mM ethylenediamine tetra-acetate (EDTA), 1% NP-40, 0.1% sodium dodecyl sulfate (SDS)) and total protein was extracted from the homogenates. The concentration of protein extracted was measured using a protein assay kit (Pierce; Rockford, IL, USA) and adjusted with equal volumes of 2 × 4% SDS sample buffer. The samples were boiled for 5 minutes (min) followed by loading on a 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel (30 µg protein/per well) for electrophoresis using a Bio-Rad mini gel apparatus at 40 mA/gel for 45 min. The fractionized protein on the gel was transferred onto a polyvinylidene fluoride (PVDF) membrane (Millipore) and electrophoresed at 300 mA for 90 min. The membrane was first probed with AT2R primary antibodies (rabbit polyclonal to angiotensin II type 2 receptor, ab78747, Abcam, 1:1000 dilution) and secondary antibody (goat anti-rabbit immunoglobulin G-horseradish peroxidase (IgG-HRP), Santa Cruz Biotechnology Inc., CA, USA, 1:5000), and then treated with enhanced chemiluminescence substrate (Pierce; Rockford, IL, USA) for 5 min at room temperature. The bands on the membrane were visualized and analyzed using UVP BioImaging Systems. After obtaining the AT2R blot density, the membrane was treated with Restore Western Blot Stipping Buffer (Thermo Scientific) to remove the AT2R signal, followed by probing with AT1R primary antibodies (AT1R rabbit polyclonal IgG, sc-1173, Santa Cruz, 1:500) and finally with GAPDH primary antibodies (GAPDH mouse monoclonal IgG, sc-32233, Santa Cruz, 1:1000) using the same process as the AT2R antibodies to obtain the AT1R and GAPDH blot densities. The final reported data are the normalized AT2R and AT1R band density divided by the GAPDH density.
Immunofluorescence staining
Mice were perfused by transcardiac perfusion using chilled 4% paraformaldehyde. The dorsal skin was removed, immersed in 4% paraformaldehyde for one to two h, and then dehydrated in 30% sucrose in phosphate-buffered saline (PBS) overnight. The skin was frozen and sectioned on a cryostat to obtain 30 µm free-floating sections. The skin sections were permeabilized for 30 min at room temperature with a solution containing 0.3% Triton X-100 dissolved in PBS. The sections were then blocked by using block solution containing 10% normal goat serum (NGS) and 0.3%Triton X-100 in PBS at room temperature for two hs. After that, the sections were incubated with primary antibody (rabbit anti-AT2R: 1:250, Abcam 78747; mouse anti-AT1R, 1:250, Abcam 9391) in 10% NGS and 0.3%Triton X-100 in PBS at 4°C overnight. Following three washes with PBS, the sections were incubated for two hs with secondary fluorescent antibodies (Donkey anti-mouse, A10038, 1:500; Donkey anti-rabbit, A21207, 1:500; Invitrogen Company). The sections were mounted with anti-fade reagent with diamidino-2-phenylindole (DAPI) (UltraCruz TM Mounting Medium, sc-24941; Santa Cruz) at room temperature. The slides were examined with a laser confocal microscope (Leica TSC STED).
Real-time RT-PCR
Total RNA was extracted from brainstem and skin with TRIZOL Reagent (Invitrogen), which was then reverse transcribed into double-stranded cDNA using iScript cDNA Synthesis Kit (BIO-RAD). Templates (50 ng cDNA) were subjected in triplicate to real-time PCR using a thermocycler (PTC-200 Peltier Thermal Cycler with CHROMO 4 Continuous Fluorescence Detector, BIO-RAD). SsoFast EvaGreen Supermix (BIO-RAD) and AT2R, AT1R, GAPDH specific primers and probes were used to quantify target gene expressions. In each experiment, GAPDH mRNA was amplified as a reference standard. Expressions of AT2R and AT1R mRNA were first normalized against GAPDH mRNA as ΔCT, and then the relative expressions in fetal tissues were compared to adult tissues using the ΔΔCT method for quantification using Opticon Monitor software (Bio-RAD). The gene-specific primers and probes were ordered from Integrated DNA Technologies (IDT, PrimeTime TM Mini qPCR Assay: Mm.TP.49.21630694 for AT1R; Mm.PT.49.16035725 for AT2R; Mm.PT.39.1 for GAPDH). Please see Table 1 for details of gene-specific primers and probes.
Statistical analyses
All data are described as the mean ± SE. A one-way analysis of variance (ANOVA) was used followed by the Student-Newman-Keuls post hoc analysis. Statistical analysis was performed with the aid of SigmaStat software. A p value < 0.05 was considered statistically significant.
Results
AT2R and AT1R protein expression in the brainstem and skin of fetal and adult mice
AT2R and AT1R protein expressions in the brainstem and skin tissues from fetal and adult mice are shown in Figure  1 . The adult brainstem displayed significantly higher AT2R expression compared to the fetal brainstem (7.6 ± 0.9 vs 0.08 ± 0.2, n = 5 per group; p < 0.05), while adult skin exhibited a lower AT2R expression compared to the fetal skin (0.04 ± 0.2 vs 0.95 ± 0.4, n = 5 per group; p < 0.05). On the other hand, the adult brainstem displayed significantly lower AT1R expression compared to the fetal brainstem (0.7 ± 0.3 vs 5.9 ± 0.8, n = 5 per group; p < 0.05), while adult skin exhibited higher AT1R expression compared to the fetal skin (2.1 ± 0.5 vs 0.6 ± 0.2, n = 5 each group; p < 0.05). These data suggest up-regulated AT2R and down-regulated AT1R protein expressions in the brainstem, and down-regulated AT2R and up-regulated AT1R protein expression in skin during development from fetal life to adulthood. Figure 1 also shows that the highest AT2R protein is expressed in the adult brainstem, while the highest AT1R protein is expressed in fetal brainstem.
Short-term time course of AT2R and AT1R protein expressions
Based on the autoradiography data of Grady et al. 25 and the prevailing concept, 1,6,17-21 AT2R expression dramatically declines after birth, usually within 24 h. To determine if this concept is true, we evaluated the time course of AT2R and AT1R expressions directly after birth in the brainstem and skin. In the brainstem AT2R expression starts to up-regulate from one week after birth ( Figure 2 ), and AT1R expression starts to down-regulate from day three after birth. Adult mice display the highest AT2R and lowest AT1R expression. In skin, AT2R expression remains unchanged at least until two weeks after birth ( Figure 3 ). However, AT1R expression began to up-regulate from day three after birth. These results suggest that AT2R as well as AT1R expression in brainstem and skin do not display a dramatic alteration within 24 h after birth.
Long-term time course of AT2R and AT1R protein expressions
In this experiment, we examined the time course of AT2R and AT1R expression in brainstem and skin over a longer time course. In brainstem, AT2R began to up-regulate at two weeks after birth and AT1R began to down-regulate at one week after birth (Figure 4 ). AT2R expression gradually increased and AT1R gradually decreased until the sixth week after birth. In skin AT2R began to down-regulate and AT1R began to up-regulate from three weeks after birth ( Figure 5 ).
Expression and distribution of AT2R and AT1R in skin of fetal and adult mice
Immunofluorescence imaging indicates AT2R and AT1R expression and distribution in the skin of fetal and adult mice ( Figure 6 ). AT2R expression was higher and AT1R expression lower in fetal skin compared to adult skin. In fetal skin, the epidermis mainly expresses AT2R, while the dermis expresses mostly AT1R. In adult skin, the epidermis and hair follicles express both AT2R and AT1R, while the dermis chiefly expresses AT1R. These results suggest that fetal skin displays an expression and distribution pattern of AT2R and AT1R distinct from adult skin. Liu HW et al. 36 reported AT1R and AT2R expression profiles in human skin Table 1 . Gene-specific primers and probes for real-time reverse transcription-polymerase chain reaction (RT-PCR) (from IDT database).
Name of genes (Accession No.)
Sequences nt   Probe  56-FAM/TCT GGT GAT /ZEN/GGC TTT CTT GGA GGG /3IABkFQ  24  Mouse AT1R (NM_177322)  Primer 1  CTT TTC TGG GTT GAG TTG GTC T  22  Primer 2  GGC TGG CAT TTT GTC TGG of fetal life. They found that, at 11-19 weeks of gestation, human fetal skin intensely expressed AT2R and faintly expressed AT1R. In these samples, the AT2R appeared to be mainly located in the suprabasal epidermis, a very similar phenomena to our observation here in mouse fetal skin.
AT2R and AT1R mRNA expression in the brainstem and skin of fetal and adult mice
AT2R and AT1R mRNA expressions in the brainstem and skin tissues from fetal and adult mice are shown in Figure  7 . There were no significant differences in both AT2R and AT1R mRNA of the brainstem between fetal and adult mice, suggesting mRNA expressions for these two receptors in brainstem were not altered during development. On the other hand, adult mouse skin displayed significantly lower AT2R mRNA (0.4 ± 0.1 vs 1.8 ± 0.3, n = 5 per group; p < 0.01) and significantly higher AT1R mRNA (1.3 ± 0.2 vs 0.6 ± 0.2, n = 5 per group; p < 0.05) compared to fetal mouse skin. These data suggest down-regulated AT2R mRNA and up-regulated AT1R mRNA expressions in the skin during development from fetal life to adulthood.
Discussion
AT2R expression is believed to dramatically change during development. The following two prevailing concepts of the ontogeny of this receptor are that: (i) AT2R is abundantly expressed in fetal tissues, but after birth it rapidly regresses to a very low level or even disappears; (ii) in the fetus, AT2R is the predominant subtype expressed. 1,6,17-21 AT2R therefore has been believed to play a crucial role in embryonic growth and development. In the adult animal, however, this receptor is regressed and expressed at very low levels in most tissues and organs, and in case of tissue injury, AT2R is strongly up-regulated in adult organisms. Yet the following observations do not support this dogma: (i) AT2R knockout mice demonstrate apparently normal embryogenesis; 37, 38 (ii) in contrast to promoting development and growth, AT2R exerts profoundly anti-proliferation and anti-growth effects both in vivo and in vitro; 8, 20, [39] [40] [41] [42] [43] (iii) in fetal sheep, both central and peripheral administration of Ang II evokes AT1R-mediated pressor respon ses, 10-13,44-46 strongly suggesting that AT1R, but not AT2R, is the predominant angiotensin II receptor subtype in the fetus; (iv) in the adult rat and mouse, a functional AT2R has recently been demonstrated to exist in the brain 15, 16, 47 and kidney. [48] [49] [50] [51] The above evidence raises serious doubts of the current view concerning AT2R maturation and function. The ontogeny of angiotensin II receptors therefore should be re-evaluated. The literature indicates that the general concept of AT2R maturation is primarily based on observations from autoradiography, [22] [23] [24] [25] competitive ligand binding, [26] [27] [28] [29] and in situ hybridization. [30] [31] [32] [33] These experiments were carried out 20 years ago. Radioligand binding assays evaluate the affinity of the ligand to the receptor. In situ hybridization usually can locate the target mRNA but does not provide information to allow for quantitative evaluation. Notably, the literature lacks reports on observing developmental changes that occur in the receptor protein by using more direct measurement assays such as Western blot analysis. Moreover, there are no reports of AT2R mRNA expression during development evaluated by real-time RT-PCR, which is a more precise quantitative measure of mRNA than in situ hybridization.
Because of the above uncertainty regarding the accepted doctrines of AT2R expression and maturation, we recently carried out a series of experiments to directly evaluate the expression profile of the AT2R protein during development by employing Western blot analysis. 35 First, we found that, at least in brainstem, liver, and kidney, adult rats exhibit a significantly higher AT2R protein expression as compared to the fetus. 35 Second, we reconfirmed this finding in adult and fetal mice. 34 In the mouse, both the mature-AT2R (membrane-bound) and immature-AT2R (cytoplasmic) protein are present at 10 times higher levels in the adult as compared to the fetus. In a time-course experiment using fetus to 6-week-old mice, we found a gradual increase of AT2R protein expression and a gradual decrease in AT1R protein expression, which display a strong negative correlation between these two receptor expressions over the range of developmental ages studied. 34 Our data clearly reveal a developmental profile of AT2R protein expression that distinctly differs from the conventionally held concept.
A major question arises as to the reason for the discrepancy between the radioligand binding data in the literature and our data based primarily on Western blot analysis. The traditional concept that the AT2R is abruptly reduced after birth was derived from an autoradiographic image reported by Grady et al. 25 In Figure 1 from the paper by Grady et al., a high AT2R density in the fetus can clearly be seen. This density was dramatically reduced after birth. However, on closer inspection, we observed that the majority of the AT2R radioactive signal was confined to the outline of fetal rats, implying that the reported high AT2R expression in the fetus and its dramatic decline after birth may be valid only for the skin. Therefore, the discrepancy between our observation and the generally accepted concept might be derived from the different developmental profiles of AT2R expression between skin and the tissues observed in our study.
The data from the current experiment clearly confirm our hypothesis. Fetal skin displayed higher AT2R than adult skin, and the fetal brainstem exhibited a lower AT2R compared to adult brainstem. The discrepancy between the traditional concept 1,6,17-21 and our findings 34, 35, 52 concerning AT2R ontogeny now seem clear. We believe that the prevailing doctrine of AT2R maturation was derived from the phenomena observed in skin. Unfortunately, this concept has penetrated the literature and is generally accepted. Based on our previous studies, 34, 35, 52 the autoradiography data from other laboratories, 25, 53 and the results from the current study (Figure 1 ), we believe that, during development from fetal life to adulthood, AT2R expression is gradually up-regulated in brain and viscera, but down-regulated in skin. We should indicate that, however, in addition to skin, Grady et al. 25 also reported a higher AT2R expression in fetal intestinal mucosa and vertebra, suggesting these two tissues as the "untypical" as skin regarding AT2R expression during development. While it would be of interest to look at these two tissues using Western blotting, we did not carry this out because of the difficulty in extracting protein from fetal intestinal mucosa (too tiny) and from adult vertebra (too hard).
Although we clearly demonstrated high AT2R protein expression localized in fetal skin, the same phenomena that was detected by autoradiography, 25, 53 we failed to find a dramatic decline of this receptor immediately after birth (within 24 h). In contrast, skin AT2R remained high and unaltered from the fetus until at least two weeks after birth (Figure 3 ). By week 3, AT2R protein expression in skin gradually declined ( Figure 5 ). The reason for this discrepancy is unknown. It may be due to the species differences used in these two experiments (rat vs mouse). Similarly, the brainstem exhibited lower AT2R expression with no change from fetus until three days after birth (Figure 2 ). From week 1 after birth, AT2R expression in the brainstem gradually increased (Figure 4 ). Another discrepancy between our data and the autoradiographic results 25, 53 that remains to be clarified is that we found abundant AT1R expression in fetal brain. Again, the reason for this discrepancy is not clear. However, functional data obtained from in vivo experiments document AT1R-mediated responses in the fetal brain, which supports our findings. For example, in ovine fetus, Zu and colleagues find that intracerebroventricular (icv) injection of Ang II evoked a significant increase in mean arterial blood pressure, 12, 46 which was completely abolished by the AT1R blocker Losartan, but not by the AT2R antagonist PD123319, 10, 45 suggesting the AT1R is the predominant receptor even in the fetus.
Another interesting finding from the present experiment is the distinct tissue distribution of AT2R in fetal life compared to adulthood. The fetal mouse displayed a significantly higher AT2R in skin than that in brainstem, while the adult mouse exhibited a substantially higher AT2R in brainstem than that in skin ( Figure 1 ). These data are partially supported by a previous study using autoradiographic analysis. Millan et al. 53 found intense Ang II binding in skin and no binding in the brain of 19-day-old fetal rats. This Ang II binding in fetal skin was then identified as the AT2R. 25 The functional significance of these altered tissue distributions during development is unknown, but implies an important role of AT2R in fetal skin and in adult brain.
In addition to AT2R, the alterations of the AT1R protein expression profile observed in this study are of interest. In almost all cases in the current study, the alterations of AT1R expression during development were opposite that of AT2R expression. Adult skin expresses higher AT1R protein than fetal skin, while fetal brainstem expressed more AT1R than adult brainstem (Figure 1) . The time course data demonstrated that AT1R is gradually up-regulated in skin (Figures 3  and 5 ) and gradually down-regulated in brainstem (Figures 2  and 4 ) during development from fetal life to adulthood. In other words, during development, tissues expressing high AT1R usually display lower AT2R, and vice versa. Indeed, a strong, negative correlation between AT1R and AT2R expression from fetal life to adulthood was clearly demonstrated in a previous study from this laboratory. 34 Reports in the literature suggest that during development, AT2R mRNA is down-regulated in brain, 30 heart, 31 kidney, 32 and adrenal. 33 However, these data were derived from in situ hybridization, [30] [31] [32] [33] a technique primarily examining the location of target mRNA. Employing real-time RT-PCR in the current study, we failed to detect significant differences in AT2R and AT1R mRNA expression of the brainstem between fetal and adult mice (Figure 7) , implying that potential post-transcriptional mechanism(s), such as microRNA or dimerization, might participate in the developmental alterations of receptor protein expression in the brain. However, we did find that fetal skin displayed a significantly higher AT2R mRNA and lower AT1R mRNA compared to adult skin, suggesting that transcriptional mechanism(s) contribute to the developmental changes in these two receptors of the skin.
In summary, the primary purpose of the present study was to explain the discrepancy between our findings by Western blot and the previous studies using autoradiography to show changes in AT2R maturation. The data obtained from the current experiment solidly support our hypothesis. In addition, the results from this study also point to a very interesting phenomenon that both AT2R and AT1R display distinct developmental expression profiles between skin and brainstem. This phenomenon raises an attractive question concerning protein expression regulation during development: How does one protein display an opposite expression pattern in different tissues of the same animal during development? The mechanism(s) underlying this differential regulation of these two receptor proteins requires further investigation.
